S. Mogali

发表

The effects of acute oral naltrexone pretreatment on the abuse potential of intranasal methamphetamine, and the relationship between reward/punishment sensitivity and methamphetamine’s effects

H. Kranzler, N. Vadhan, S. Comer, 2022, Behavioural pharmacology.

Effects of Acute Oral Naltrexone on the Subjective and Physiological Effects of Oral D-Amphetamine and Smoked Cocaine in Cocaine Abusers

S. Vosburg, D. Martínez, P. Saccone, 2013, Neuropsychopharmacology.

Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: Reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone

S. Vosburg, Z. Cooper, M. Sullivan, 2013, PAIN®.

Gabapentin increases the abuse liability of alcohol alone and in combination with oxycodone in participants with co-occurring opioid and alcohol use disorder

S. Evans, S. Comer, R. Foltin, 2022, Pharmacology Biochemistry and Behavior.

The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users

R. Ciccocioppo, M. Sullivan, S. Comer, 2016, Physiology & Behavior.

Substituent Effects in Gas-Phase Substitutions and Eliminations: β-Halo Substituents. Solvation Reverses SN2 Substituent Effects

S. Gronert, A. Pratt, S. Mogali, 2001 .

Polydrug abuse: a review of opioid and benzodiazepine combination use.

S. Comer, Sandra D Comer, Jermaine D. Jones, 2012, Drug and alcohol dependence.

Risks, Management, and Monitoring of Combination Opioid, Benzodiazepines, and/or Alcohol Use

S. Comer, J. Gudin, Jermaine D. Jones, 2013, Postgraduate medicine.

Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine‐maintained heroin users

M. Sullivan, S. Comer, Jermaine D. Jones, 2015, Addiction biology.

Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder.

F. Levin, S. Comer, J. Manubay, 2020, Drug and alcohol dependence.

The PPARγ Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety

R. Ciccocioppo, A. Bisaga, S. Comer, 2018, Journal of psychoactive drugs.

Methylphenidate modifies the motion of the circadian clock Lamotrigine in mood disorders and cocaine dependence Cortical glutamate in postpartum depression Effects of Ibudilast on the Subjective , Reinforcing and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence

Kirk W. Johnson, M. Sullivan, S. Comer, 2017 .

Treatment of Pain and Opioid Abuse

S. Comer, S. Mogali, 2013 .

Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential

R. Ciccocioppo, A. Bisaga, S. Comer, 2017, Pharmacology Biochemistry and Behavior.

Abuse liability of intravenous buprenorphine vs. buprenorphine/naloxone: Importance of absolute naloxone amount.

S. Comer, J. Manubay, Jermaine D. Jones, 2017, Drug and alcohol dependence.

Minocycline attenuates oxycodone-induced positive subjective responses in non-dependent, recreational opioid users

S. Comer, J. D. Jones, S. Mogali, 2021, Pharmacology Biochemistry and Behavior.

Patterns of opioid use and co-morbidity in non-treatment-seeking individuals with opioid use disorder

M. Sullivan, S. Comer, J. Manubay, 2015 .

Baseline characteristics of patients predicting suitability for rapid naltrexone induction.

M. Pavlicova, E. Nunes, M. Sullivan, 2015, The American journal on addictions.

Baseline characteristics of patients predicting suitability for rapid naltrexone induction.

M. Pavlicova, E. Nunes, M. Sullivan, 2014, The American journal on addictions.

Assessing the contribution of opioid- and dopamine-related genetic polymorphisms to the abuse liability of oxycodone

S. Comer, J. Manubay, Jermaine D. Jones, 2019, Pharmacology Biochemistry and Behavior.

Polydrug abuse: a review of opioid and benzodiazepine combination use.

S. Comer, Jermaine D. Jones, S. Mogali, 2012, Drug and alcohol dependence.

The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users

R. Ciccocioppo, M. Sullivan, S. Comer, 2016, Physiology & Behavior.

Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence

M. Sullivan, S. Comer, J. Manubay, 2017, Neuropsychopharmacology.

Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: Reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone

S. Vosburg, Z. Cooper, M. Sullivan, 2013, PAIN®.